Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T69985 | Lifirafenib HCl | ||
Lifirafenib, also known as Beigene-283, is a Novel potent and selective RAF Kinase and EGFR inhibitor. BGB-283-displays Potent Antitumor Activity in B-RAF Mutated Colorectal Cancers. In vitro, BGB-283 potently inhibits B-RAFV600E-activated ERK phosphorylation and cell proliferation. It demonstrates selective cytotoxicity and preferentially inhibits proliferation of cancer cells harbouring B-RAFV600E and EGFR mutation/amplification. In B-RAFV600E CRC cell lines, BGB-283 effectively inhibits the ... | |||
T71902 |
CHEMBL94431
|
||
CHEMBL94431 is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. |